China M&A To Accelerate In 2013 To Fill Gaps In Fragmented Market: KPMG Report
This article was originally published in PharmAsia News
Executive Summary
China’s drug and device industry looks set to keep up a fast pace of mergers and acquisitions in 2013 as companies see solid demand prospects and fragmented market sectors, says a KPMG report.